These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 34151207)
1. Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB Liu Z; Iyer MR; Godlewski G; Jourdan T; Liu J; Coffey NJ; Zawatsky CN; Puhl HL; Wess J; Meister J; Liow JS; Innis RB; Hassan SA; Lee YS; Kunos G; Cinar R ACS Pharmacol Transl Sci; 2021 Jun; 4(3):1175-1187. PubMed ID: 34151207 [TBL] [Abstract][Full Text] [Related]
2. A novel peripheral cannabinoid 1 receptor antagonist, AJ5012, improves metabolic outcomes and suppresses adipose tissue inflammation in obese mice. Han JH; Shin H; Park JY; Rho JG; Son DH; Kim KW; Seong JK; Yoon SH; Kim W FASEB J; 2019 Mar; 33(3):4314-4326. PubMed ID: 30566396 [TBL] [Abstract][Full Text] [Related]
3. Low brain CB1 receptor occupancy by a second generation CB1 receptor antagonist TM38837 in comparison with rimonabant in nonhuman primates: a PET study. Takano A; Gulyás B; Varnäs K; Little PB; Noerregaard PK; Jensen NO; Elling CE; Halldin C Synapse; 2014 Mar; 68(3):89-97. PubMed ID: 24293119 [TBL] [Abstract][Full Text] [Related]
4. Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice. Song D; Bandsma RH; Xiao C; Xi L; Shao W; Jin T; Lewis GF Diabetologia; 2011 May; 54(5):1181-9. PubMed ID: 21340622 [TBL] [Abstract][Full Text] [Related]
5. Hepatic targeting of the centrally active cannabinoid 1 receptor (CB Hirsch S; Hinden L; Naim MB; Baraghithy S; Permyakova A; Azar S; Nasser T; Portnoy E; Agbaria M; Nemirovski A; Golomb G; Tam J J Control Release; 2023 Jan; 353():254-269. PubMed ID: 36442615 [TBL] [Abstract][Full Text] [Related]
6. A dopamine D1 receptor-dependent β-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice. Urs NM; Daigle TL; Caron MG Neuropsychopharmacology; 2011 Feb; 36(3):551-8. PubMed ID: 20980993 [TBL] [Abstract][Full Text] [Related]
7. β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner. Nguyen PT; Schmid CL; Raehal KM; Selley DE; Bohn LM; Sim-Selley LJ Biol Psychiatry; 2012 Apr; 71(8):714-24. PubMed ID: 22264443 [TBL] [Abstract][Full Text] [Related]
9. SGIP1 alters internalization and modulates signaling of activated cannabinoid receptor 1 in a biased manner. Hájková A; Techlovská Š; Dvořáková M; Chambers JN; Kumpošt J; Hubálková P; Prezeau L; Blahos J Neuropharmacology; 2016 Aug; 107():201-214. PubMed ID: 26970018 [TBL] [Abstract][Full Text] [Related]
10. The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake. Cooper ME; Regnell SE Br J Clin Pharmacol; 2014 Jan; 77(1):21-30. PubMed ID: 23452341 [TBL] [Abstract][Full Text] [Related]
11. Mutations in the 'DRY' motif of the CB1 cannabinoid receptor result in biased receptor variants. Gyombolai P; Tóth AD; Tímár D; Turu G; Hunyady L J Mol Endocrinol; 2015 Feb; 54(1):75-89. PubMed ID: 25510402 [TBL] [Abstract][Full Text] [Related]